Rehmann Capital Advisory Group’s Zimmer Biomet ZBH Stock Holding History

Rehmann Capital Advisory Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$54.9K	Sell	411 -5	-1%	-$646	0.01%	592
2019 Q2	$47.6K	Hold	416	–	–	0.01%	852
2019 Q1	$51.6K	Buy	416 +33	+9%	+$3.75K	0.01%	801
2018 Q4	$38.6K	Sell	383 -26	-6%	-$2.92K	0.01%	671
2018 Q3	$52.2K	Buy	409 +39	+11%	+$4.64K	0.01%	777
2018 Q2	$40K	Sell	370 -168	-31%	-$18.3K	0.01%	861
2018 Q1	$57K	Buy	+538	New	+$62.5K	0.01%	710
2017 Q4	–	Sell	-2,025	Closed	-$230K	–	402
2017 Q3	$230K	Buy	2,025 +158	+8%	+$18.2K	0.04%	328
2017 Q2	$233K	Sell	1,867 -3	-0.2%	-$356	0.04%	313
2017 Q1	$222K	Buy	+1,870	New	+$212K	0.04%	348

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Rehmann Capital Advisory Group's ZBH Position: Q3 2019 in Review

Rehmann Capital Advisory Group reduced its Zimmer Biomet (ZBH) stake by 1.2% in Q3 2019, selling an estimated $646 and leaving 411 shares worth $54.9K. The position accounts for 0.01% of the portfolio, ranked #592.

Rehmann Capital Advisory Group first reported a position in ZBH in Q1 2017 and has held it in 10 quarters since. The position peaked at $233K in Q2 2017. 896 funds tracked by Wall St. Rank hold ZBH as of Q3 2019.

Rehmann Capital Advisory Group held 411 shares of Zimmer Biomet worth $54.9K as of Q3 2019.
Rehmann Capital Advisory Group sold 5 Zimmer Biomet shares in Q3 2019, an estimated $646.
Zimmer Biomet made up 0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #592 holding.
Rehmann Capital Advisory Group first reported a position in Zimmer Biomet in Q1 2017 and has held it in 10 quarters since.
Rehmann Capital Advisory Group's Zimmer Biomet position peaked at $233K in Q2 2017.
896 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.